FDA/CDC

U.S. syphilis cases reach 70-year high


 

Cases of the sexually transmitted disease syphilis soared in 2021 to the highest total in more than 70 years, a new report says.

Earlier in 2023, the Centers for Disease Control and Prevention issued preliminary projections that syphilis rates had made a startling jump from 2020 to 2021. But now that health officials have finalized all of the 2021 data, the increase is worse than what was announced back in March.

In just a 1-year period, from 2020 to 2021, cases increased by 32%, to 176,713, according to newly finalized data from the CDC. That is the highest total number of syphilis cases the U.S. has seen since 1950.

The total number of STD cases in the U.S. in 2021 was 2.5 million, including 1.6 million cases of chlamydia, which was up 4% over the year prior.

A CDC official labeled the situation an epidemic.

“The reasons for the ongoing increases are multifaceted – and so are the solutions,” said Leandro Mena, MD, MPH, director of the CDC’s STD prevention division, in a statement. “It will take many of us working together to effectively use new and existing tools to increase access to quality sexual health care services for more people and to encourage ongoing innovation and prioritization of STI prevention and treatment in this country.”

Syphilis causes sores and rashes and, left untreated over a long period of time, can cause severe problems in organs, the brain, and the nervous system. Untreated congenital syphilis can lead to stillbirth. The treatment for syphilis is antibiotics.

The CDC called a 32% increase from 2020 to 2021 of congenital syphilis cases “alarming,” reporting that it resulted in 220 stillbirths and infant deaths in 2021.

The rise in STDs during the pandemic has been attributed to decreased attention and resources devoted to sexual health. Opioid use is also considered a contributing factor.

A version of this article first appeared on WebMD.com.

Recommended Reading

Implementation of a Multidisciplinary Team–Based Clinical Care Pathway Is Associated With Increased Surgery Rates for Infective Endocarditis
Journal of Clinical Outcomes Management
COVID can mimic prostate cancer symptoms
Journal of Clinical Outcomes Management
Old-school printer helps scientists quickly spot bacteria in blood
Journal of Clinical Outcomes Management
eNose knows S. aureus in children with cystic fibrosis
Journal of Clinical Outcomes Management
Meet the JCOM Author with Dr. Barkoudah: A Multidisciplinary Team–Based Clinical Care Pathway for Infective Endocarditis
Journal of Clinical Outcomes Management
High-dose prophylactic anticoagulation benefits patients with COVID-19 pneumonia
Journal of Clinical Outcomes Management
Deadly bacteria in recalled eye drops can spread person-to-person
Journal of Clinical Outcomes Management
Likely cause of mysterious hepatitis outbreak in children identified
Journal of Clinical Outcomes Management
SARS-CoV-2 crosses placenta and infects brains of two infants: ‘This is a first’
Journal of Clinical Outcomes Management
Antimicrobial resistance requires a manifold response
Journal of Clinical Outcomes Management